Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Baxter
Medtronic
McKesson
Express Scripts

Last Updated: November 27, 2022

Benazepril hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for benazepril hydrochloride and what is the scope of freedom to operate?

Benazepril hydrochloride is the generic ingredient in four branded drugs marketed by Amneal Pharms, Ani Pharms, Annora Pharma, Aurobindo Pharma, Cadila, Chartwell Rx, Genpharm, Heritage Pharma, Prinston Inc, Rising, Sun Pharm Inds Ltd, Teva, Validus Pharms, Apotex, Aurobindo Pharma Usa, Mylan Pharms Inc, and Sandoz, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for benazepril hydrochloride. Twenty-eight suppliers are listed for this compound.

Summary for benazepril hydrochloride
Recent Clinical Trials for benazepril hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Northwell HealthPhase 2
Lupus Research AlliancePhase 2
Shanghai Children's HospitalPhase 2

See all benazepril hydrochloride clinical trials

Pharmacology for benazepril hydrochloride

US Patents and Regulatory Information for benazepril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 078794-003 Aug 21, 2014 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Aurobindo Pharma Usa BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 076688-002 Feb 11, 2004 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Genpharm BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076476-004 Feb 11, 2004 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for benazepril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Validus Pharms LOTENSIN benazepril hydrochloride TABLET;ORAL 019851-001 Jun 25, 1991 See Plans and Pricing See Plans and Pricing
Validus Pharms LOTENSIN benazepril hydrochloride TABLET;ORAL 019851-004 Jun 25, 1991 See Plans and Pricing See Plans and Pricing
Validus Pharms LOTENSIN benazepril hydrochloride TABLET;ORAL 019851-003 Jun 25, 1991 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Express Scripts
Colorcon
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.